140 related articles for article (PubMed ID: 26279446)
1. Lgr5-Positive Cells are Cancer-Stem-Cell-Like Cells in Gastric Cancer.
Wang Z; Liu C
Cell Physiol Biochem; 2015; 36(6):2447-55. PubMed ID: 26279446
[TBL] [Abstract][Full Text] [Related]
2. Role of Lgr5-positive cells in colorectal cancer.
Ding H; Wang C
Tumour Biol; 2015 Sep; 36(9):6759-64. PubMed ID: 25835970
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
4. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
5. AQP5 complements LGR5 to determine the fates of gastric cancer stem cells through regulating ULK1 ubiquitination.
Zhao R; He B; Bie Q; Cao J; Lu H; Zhang Z; Liang J; Wei L; Xiong H; Zhang B
J Exp Clin Cancer Res; 2022 Nov; 41(1):322. PubMed ID: 36372898
[TBL] [Abstract][Full Text] [Related]
6. FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells.
Choi Y; Park J; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Lee BL
Biochem Biophys Res Commun; 2017 Nov; 493(3):1349-1355. PubMed ID: 28970066
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
8. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
9. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
10. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
11. Rspondin-1 contributes to the progression and stemness of gastric cancer by LGR5.
Wang C; Gao Y; Liang W; Lu Y; Zhang K; Wu D; Zhuang Z; Li K; Qiao Z; Xi H; Chen L
Biochem Biophys Res Commun; 2022 Oct; 627():91-96. PubMed ID: 36030657
[TBL] [Abstract][Full Text] [Related]
12. Stem cells in gastric cancer.
Zhao Y; Feng F; Zhou YN
World J Gastroenterol; 2015 Jan; 21(1):112-23. PubMed ID: 25574084
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
14. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.
Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C
Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644
[TBL] [Abstract][Full Text] [Related]
15. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach.
Leushacke M; Tan SH; Wong A; Swathi Y; Hajamohideen A; Tan LT; Goh J; Wong E; Denil SLIJ; Murakami K; Barker N
Nat Cell Biol; 2017 Jul; 19(7):774-786. PubMed ID: 28581476
[TBL] [Abstract][Full Text] [Related]
16. Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.
Pajuelo-Lozano N; Alcalá S; Sainz B; Perona R; Sanchez-Perez I
Theranostics; 2020; 10(21):9601-9618. PubMed ID: 32863948
[No Abstract] [Full Text] [Related]
17. Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis.
Jang BG; Lee BL; Kim WH
PLoS One; 2013; 8(12):e82390. PubMed ID: 24340024
[TBL] [Abstract][Full Text] [Related]
18. Gastric Lgr5(+) stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice.
Li XB; Yang G; Zhu L; Tang YL; Zhang C; Ju Z; Yang X; Teng Y
Cell Res; 2016 Jul; 26(7):838-49. PubMed ID: 27091432
[TBL] [Abstract][Full Text] [Related]
19. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers.
Wu C; Xie Y; Gao F; Wang Y; Guo Y; Tian H; Li Y; Fan W
Gene; 2013 Aug; 525(1):18-25. PubMed ID: 23664892
[TBL] [Abstract][Full Text] [Related]
20. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
